Notably, although LSD1i treatment induced GFI1 expression, because it disrupted binding of CoREST-LSD1 to GFI1, LSD1i treatment prevented GFI1-mediated repression, causing derepression of GFI1 target genes associated with AML cell differentiation. The gene discussed is KDM1A; the disease is acute myeloid leukemia.